-
1
-
-
0025037094
-
Eosinophilic inflammation in asthma
-
Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039 (Pubitemid 20336962)
-
(1990)
New England Journal of Medicine
, vol.323
, Issue.15
, pp. 1033-1039
-
-
Bousquet, J.1
Chanez, P.2
Lacoste, J.Y.3
Barneon, G.4
Ghavanian, N.5
Enander, I.6
Venge, P.7
Ahlstedt, S.8
Simony-Lafontaine, J.9
Godard, P.10
Michel, F.-B.11
-
2
-
-
0036900913
-
Eosinophilic inflammation in sputum of poorly controlled asthmatics
-
Romagnoli M, Vachier I, Tarodo de la Fuente P, et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J 2002;20:1370-1377
-
(2002)
Eur Respir J
, vol.20
, pp. 1370-1377
-
-
Romagnoli, M.1
Vachier, I.2
Tarodo De La Fuente, P.3
-
3
-
-
15144358845
-
Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
-
Shi HZ, Xiao CQ, Zhong D, et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998;157:204-209 (Pubitemid 28071284)
-
(1998)
American Journal of Respiratory and Critical Care Medicine
, vol.157
, Issue.1
, pp. 204-209
-
-
Shi, H.-Z.1
Xiao, C.-Q.2
Zhong, D.3
Qin, S.-M.4
Liu, Y.5
Liang, G.-R.6
Xu, H.7
Chen, Y.-Q.8
Long, X.-M.9
Xie, Z.-F.10
-
5
-
-
33751023463
-
Imatinib mesylate for the treatment of hypereosinophilic syndromes
-
Antoniu SA. Imatinib mesylate for the treatment of hypereosinophilic syndromes. Curr Opin Investig Drugs 2006;7:980-984 (Pubitemid 44756123)
-
(2006)
Current Opinion in Investigational Drugs
, vol.7
, Issue.11
, pp. 980-984
-
-
Antoniu, S.A.1
-
6
-
-
36749065556
-
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
-
DOI 10.1164/rccm.200701-085OC
-
Flood-page P, Swenson C, Faiferman I, et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 2007;176:1062-1071 (Pubitemid 350223751)
-
(2007)
American Journal of Respiratory and Critical Care Medicine
, vol.176
, Issue.11
, pp. 1062-1071
-
-
Flood-Page, P.1
Swenson, C.2
Faiferman, I.3
Matthews, J.4
Williams, M.5
Brannick, L.6
Robinson, D.7
Wenzel, S.8
Busse, W.9
Hansel, T.T.10
Barnes, N.C.11
-
7
-
-
61849086181
-
Mepolizumab and exacerbations of refractory eosinophilic asthma
-
Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-984
-
(2009)
N Engl J Med
, vol.360
, pp. 973-984
-
-
Haldar, P.1
Brightling, C.E.2
Hargadon, B.3
-
8
-
-
61849155730
-
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia
-
Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-993
-
(2009)
N Engl J Med
, vol.360
, pp. 985-993
-
-
Nair, P.1
Pizzichini, M.M.2
Kjarsgaard, M.3
-
9
-
-
0034526865
-
Proceedings of the ATS workshop on refractory asthma: Current understanding, recommendations, and unanswered questions
-
American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162:2341-2351 (Pubitemid 32051710)
-
(2000)
American Journal of Respiratory and Critical Care Medicine
, vol.162
, Issue.6
, pp. 2341-2351
-
-
Wenzel, S.E.1
Fahy, J.V.2
Irvin, C.3
Peters, S.P.4
Spector, S.5
Szefler, S.J.6
Casale, T.B.7
Cloutier, M.M.8
Elias, J.A.9
Liu, M.C.10
Taggert, V.11
-
10
-
-
6644229440
-
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
-
Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148
-
(2000)
Lancet
, vol.356
, pp. 2144-2148
-
-
Leckie, M.J.1
Ten Brinke, A.2
Khan, J.3
-
11
-
-
0037718532
-
Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions
-
Buttner C, Lun A, Splettstoesser T, et al. Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions. Eur Respir J 2003;21:799-803
-
(2003)
Eur Respir J
, vol.21
, pp. 799-803
-
-
Buttner, C.1
Lun, A.2
Splettstoesser, T.3
-
12
-
-
40949146020
-
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
-
Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008;358:1215-1228
-
(2008)
N Engl J Med
, vol.358
, pp. 1215-1228
-
-
Rothenberg, M.E.1
Klion, A.D.2
Roufosse, F.E.3
|